Qrg Capital Management, Inc. Repligen Corp Transaction History
Qrg Capital Management, Inc.
- $9.71 Trillion
- Q4 2024
A detailed history of Qrg Capital Management, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Qrg Capital Management, Inc. holds 2,342 shares of RGEN stock, worth $360,340. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,342
Previous 3,642
35.69%
Holding current value
$360,340
Previous $542 Million
37.8%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding RGEN
# of Institutions
475Shares Held
54.8MCall Options Held
314KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.16 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$984 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$785 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$250 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$219 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.54B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....